Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case report

BACKGROUND: Simultaneous multiple myeloma (MM) and pulmonary adenocarcinoma is a rare occurrence, and thus, treatment is a challenge. This study reports on 1 such case of MM with concurrent lung cancer, where an accurate diagnosis was made and the patient underwent treatment for both cancers. CASE S...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Wenli, Zhu, Xinghu, Yang, Jingke, Mei, Zhenyang, Deng, Mei, Lin, Quande, Song, Yongping, Yin, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228690/
https://www.ncbi.nlm.nih.gov/pubmed/28072730
http://dx.doi.org/10.1097/MD.0000000000005787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228690/
https://www.ncbi.nlm.nih.gov/pubmed/28072730
http://dx.doi.org/10.1097/MD.0000000000005787

Ejemplares similares